Patent Expiry
NUVL: JIDEYTRO: recorded patent 12630560 expiry
September 30, 2042 · ZIDESAMTINIB. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- September 30, 2042
- Company
- Nuvalent, Inc. (NUVL)
- Drug
- ZIDESAMTINIB
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Patent Expiry
JIDEYTRO: recorded patent 12630560 expiry
Orange Book application NDA220185, product 001, listed patent 12630560 expiry. Overall loss of exclusivity and current company rights: unknown.FDA source
- Company
- Nuvalent, Inc. (NUVL)
- Drug
- ZIDESAMTINIB